Extended schedule, escalated dose temozolomide versus dacarbazine in stage IV melanoma: Final results of a randomised phase III study (EORTC 18032)Poulam M. Patel, Alan Spatz, John A. Thompson et al.|European Journal of Cancer|2011Cited by 210